Nothing written yet for this company.
No news written yet.
| Period | 226950 | KOSDAQ | Difference |
|---|---|---|---|
| 1 week | -9.4% | -3.0% | -6.5% |
| 1 month | -19.9% | +4.2% | -24.1% |
| 3 months | -40.9% | -22.5% | -18.4% |
| 6 months | -41.3% | -16.9% | -24.5% |
| Year to date | -31.7% | -12.1% | -19.6% |
| 1 year | +17.2% | +1.0% | +16.2% |
Closed at 11% of the way from its 52-week low (₩81,700) to its 52-week high (₩207,000).
Olix Pharmaceuticals, Inc. does research and development in science and engineering in South Korea. It is listed on KOSDAQ, was founded in 2010, is based in Gyeonggi, and has revenue of tens of billions of won.
| Sector | Biopharma | Employees | |
| Market | KOSDAQ | Founded | 2010 |
| Korean name | 올릭스 | Head office | Gyeonggi |
| Symbol | Last Price |
|---|---|
| 009420Hanall Biopharma Co., Ltd. | ₩54,700 +1.5% |
| 310210Voronoi, Inc. | ₩153,000 +3.9% |
| 214370Caregen Co., Ltd. | ₩44,500 +1.5% |
| 347850D & D Pharmatech, Inc. | ₩49,200 +1.4% |
| 237690ST Pharm Co., Ltd. | ₩101,200 +2.2% |
| 140410Mezzion Pharma Co., Ltd. | ₩65,000 +0.0% |
| 068760Celltrion Pharm, Inc. | ₩40,850 +0.0% |
| 007390Naturecell Co., Ltd. | ₩23,950 +0.2% |
| 006280GC Biopharma Corp. | ₩127,600 +0.5% |
| 950160Kolon Tissue Gene, Inc. | ₩17,100 +1.1% |